La cytogénétique et classification des hémopathies malignes

References Bibliographiques

Abruzzo L.V., Jaffe E.S., Cotelingam J.D., Whang-Peng J., Del Luca V., Medeiros L.J et Am. J. Surg. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid

malignancy. Pathol. 16: 236-245. 1992.

Adams J.M., Cory S., Life-or-death decisions by the Bcl-2 protein family. Trends. Biochem. Sci. 26:

61-66. 2001.

acutemyelogenous leukemia with anormal karyotype. n. engl. j . med., 2005, 352, 254-266.

Adnane J., Gaudray P., Dionne C.A., Crumley G., Jaye M., Schlessinger J., Jeanteur P., Birnbaum

D., Theillet C., 1991

Ahmed Nacer Redhouane et Pr Hamladji Rose Marie, Pr Belhani Meriem, Pr Ardjoun Fatma

Zohra, Pr Abad Mohand Tayeb, Pr Touhami Hadj, Pr Ait Ali Hocine, Pr Zouaoui Zahia, Pr Bekadja

Mohamed Amine, Pr Ahmed Nacer Redhouane, Pr Boudjerra Nadia, Pr Sidi Mansour Nourredine,
Pr Hamladji Rose Marie, Pr Belhani Meriem, Pr Ardjoun Fatma Zohra, Pr Abad Mohand ,Tayeb,Pr

Touhami Hadj,Pr Ait Ali Hocine, Pr Zouaoui Zahia, Pr Bekadja Mohamed Amine, Pr Ahmed Nacer

Redhouane,Pr Boudjerra Nadia,Pr Sidi Mansour Nourredine,Pr Ainas Lahlou,Pr Mesli Naima,Pr Hamdi Salima, Pr Saidi Mahdia et Pr Benakli Malek ;;truc de approches épidémiologique en

algérie ;;2009.

BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene. 6: 659-663; 1991.

Bai R-Y., Dieter P., Peschel C., Morris S.W., and Duyster J., Nucleophosmin-anaplastic lymphoma

kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-ã to mediate its mitogenicity. Mol. Cell. Biol. 18: 6951-6961; 1998.

Bai R-Y., Ouyang T., Miething C., Morris S.W., Peschel C., Duyster J., Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the

phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Blood. 96: 4319-4327;2000. BELL RJ. lntroductory Fourier transforms spectroscopy. Londres: académie press, 1972. BENNETT, CATOVSKY, DANIEL, et- al (The french-american-british (fab) coopérative

BENNETT, CATOVSKY, DANIEL, et al FRENCH-AMERICAN-BRITISH (FAB) co-operative

Brown D., Kogan S., Lagasse E., Weissman I., Alcalay M., Pelicci P.G., Atwater S., Bishop J.M., PMLRARá transgene initiates murine acute promyelocytic leukemia Proc. Natl. Acad. Sci. 94:

2551-2556; 1997.

CAVE H, VAN DER WERFF TEN BOSCH J . , SUCIU S., GULDAL C , WATERKEYN C ,

CHUDOBA L PLESCH A, LORCH T, et aL high resolution multicolor-banding: a new technique Cleary ML. Oncogenic conversion of transcription factors by chromosomal translocations. Cell. 66: 619-622; 1991.

CREMER T, LANDEGENT J , BRUCKNER A, et ai. détection of chromosome aberration in the
Deininger M.W.N., Goldman J.M., and Melo J.V., the molecular biology of chronic myeloid

leukemia. Blood. 96: 3343-3356;; 2000.

Desmaze C., Brizard F., Turc-Carel C., Melot T., Delattre O., Thomas G., Aurias A., Multiple

chromosomal mechanisms generate an EWS/FLI1 or EWS/ERG fusion gene in Ewing tumors.

Cancer Genet. Cytogenet. 97: 12-19;1997.

F L A N D R I N MDS SCORING system / système de score pour les myélodysplasies. Tutorial FALINI B., MECUCCI C., TIACCI E . , ALCALAY M ROSATI R., PASQUALUCCI L . , LA

FE1NBERG P, VOGELSTEJLN B. A technique for radio Jabeling DNA restriction enzyme fragments

FEINGOED J , F E L EO E S M, SOLIGNAC M. Principes de génétique humaine, paris : Hermann, Fenrick R., Amann J.M., Lutterbach B., Wang L., Westendorf J.J., Downing J.R., Hiebert S.W

Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol. Cell. Biol. 19: 6566-6574., 1999.

for refined fish analysis of human chromosomes. C'ytogenetic cell genêt 1999; 84: 156-60. group) the chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, groupproposals for the classification of the acute leukaemias br j haematol 33 1976 451-458

He L.Z., Guidez F., Tribioli C., Peruzzi D., Ruthard M., Zelent A., Pandolfi P.P Distinct interactions

of PML-RARá and PLZF-RARá with co-repressors determine differential responses to RA in APL. Nature Genet. 18: 126-135., 1998.

Heim S., Mitelman F. Cancer Cytogenetics. Chromosomal and Molecular Genetic Aberrations of Tumor Cells. Second edition. Wiley-Liss. http://www.infobiogen.fr/services/chromosomes cancer Hernandez L., Pinyol M., Hernadez S., Bea S., Pulford K., Rosenwald A., Lamant L., Falini B., Ott G.,

Mason D.Y., Delsol G., and Campo E;TRK-Fused Gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations; Blood. 94: 3265-3268; 1999.

human interphase nucleus by visualization of spécifie target DNAs with radioactive and nonradioactive

Ibrahimi O.A., Eliseenkova A.V., Plotnikov A.N., Yu K., Ornitz D.M.,Mohammadi M Structural basis

for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA. 98: 7182-7187., 2001.

in situ hybridization techniques. Hum genêt 1986; 741: 346-5

Kuno Y., Abe A., Emi N., Lida M., Yokozawa T., Towatari M., Tanimoto M., and Saito H Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood. 97:1050-1055., 2001.

Kurzrock R., Shtalrid M., Talpaz M., Kloetzer W.S., Gutterman J.U Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. Blood. 70: 1584-1588., 1987.

Lacronique V., Boureux A., Monni R., Dumon S., Mauchauffé M., Mayeux P., Gouilleux F., Berger R., Gisselbrecht S., Ghysdael J., and Bernard O. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood. 95: 2076-2083 A., 2000. Lengauer C., Kinzler K.W., Vogelstein Genetic instabilities in human cancers. Nature. 396: 643-649 B., 1998.

Lacronique V., Boureux A., Valle V. D., Poirel H., Quang C.T., Mauchauffé M., Berthou C., Lessard M., Berger R., Ghysdael J., and Bernard O. A ;A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia. Science. 278: 1309-1312., 1997.

MANDEE! I F . , LO COCO F., PELICCI PG, MARTELLI MF, Cytoplasm nucleophosmin in

Martiat P., Mecucci C., Nizet Y., Stul M., Philippe M., Cassiman J.J., Michaux J.L., Van den Berghe

H., Sokal G P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. Leukemia. 4: 751-754., 1990.

Martin D.B., Nelson P.S From genomics to proteomics: techniques and applications in cancer research. Trends in Cell Biol. 11: S60-S65., 2001.

med., 1998, 339, 591-598.

Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa MK., Mano H., Yazaki Y., Ohki M., Hirai H.,

Generation of the AML1-EVi-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13: 504-510;1994.

Mitani K., Sato Y., Tojo A., Ishikawa F., Kobayashi Y., Miura Y., Miyazono K., Urabe A. Takaku F., Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa BCR-ABL protein. British J. Haematol. 76: 221-2251990.

Mitelman F., Johansson B., Mertens F., Mitelman database of chromosome aberrations in cancer2001. http://cgap.nci.nih.gov/Chromosomes/Mitelman.

Mohammadi M., Schlessinger J. Hubbard R., Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86: 577-587; 1996.

Okuda K., Golub T.R., Gilliland D.G., Griffin J.D p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene. 13: 1147-1152;.,.

organization for research and treatment of cancer--childhood leukemia coopérative group. n. engl. 1996j .

OTTEN J., BAKKUS M., THIELEMANS K., CRAN DC H AMP B., VILMER E., Clinical

Pane F., Frigeri F., Sindona M., Luciano L., Ferrara F., Cimino R., Meloni G., Saglio G., Salvatore F.,

Rotoli B Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood. 88: 2410-2414., 1996.

PUCCIARINI A., LISO A., VIGNETTI M., FAZI P., MEANI N., PETTIROSSI V., SAGLIO G.,

Rowley J.D The role of chromosome translocations in leukemogenesis. Sem. in Hematol. 36

(supl. 7): 59-72., séries in haematology array (0x3a828c) publication : Novartis. Édit. : g.flandrin - product.

Shannon KThe Ras signaling pathway and the molecular basis of myeloid leukemogenesis1999.. Curr. Op. In Hematol. 2: 305-308., significance of minimal residual disease in childhood acute

lymphoblastic leukemia. European. STARZA R, DIVERIO D., COLOMBO E., SANTUCCI A., BIGERNA B., PAC INI R. 1995.

Stehelin D., Varmus H.E., Bishop J.M., Vogt P.K DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature. 260: 170-173., 1976.

Strissel PS., Strick R., Rowley JD., Zeleznik-Le NJ., An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site co-localize near exon 9 in the MLL breakpoint cluster region. Blood 92: 3793-3803;1998.

Tanaka K., Tanaka T., Kurokawa M., Imai Y., Ogawa S., Mitani K., Yazaki Y., Hirai HThe AML1/ETO (MTG8) and AML1/EVi-1 leukemia-associated chimeric oncoproteins., 1998

Tanaka T., Mitani K., Kurokawa M., Ogawa S., Tanaka K., Nishida J., Yazaki Y., Shibata Y., Hirai H., Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol. 15: 2383-2392;1995.

Tlsty T.D., White A., and Sanchez J Suppression of gene Amplification in human cell Hybrids. Science. 255: 1425-1427.,. to high spécifie activity. Anal biochem 1984; 1371: 266-7 1992. Wells R.A., Catzavelos C., Kamel-Reid S Fusion of retinoic acid receptor alpha to NuMA, the

nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat. Genet. 17: 109-113., 1997.

Willis TG., Dyer MJS The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 96: 808-822., 2000.

Wilson G., Frost L., Goodeve A., Vandenberghe E., Peake I., Reilly J BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia. Blood. 89: 3064., 1997.